STOCK TITAN

Organogenesis Holdings Inc. Updates Date and Time of Presentation at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Organogenesis Holdings Inc. (Nasdaq: ORGO) announced a change in its presentation schedule for the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. The company will now present on September 21, 2020, at 2:30 p.m. Eastern Time, instead of the previously scheduled time of September 22, 2020, at 4:10 p.m. Eastern Time. A live audio webcast of the presentation will be available on the company’s website, with a replay accessible for approximately 30 days post-event. Organogenesis specializes in regenerative medicine, providing solutions for advanced wound care and surgical needs.

Positive
  • None.
Negative
  • None.

CANTON, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that the date and time of its presentation at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit has been updated.

Company management is now scheduled to conduct a presentation at the conference on Monday, September 21 at 2:30 p.m. Eastern Time. The company was previously scheduled to present on Tuesday, September 22 at 4:10 p.m. Eastern Time.

A live audio webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.

About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.

Investor Inquiries:
Westwicke Partners
Mike Piccinino, CFA

443-213-0500

Press and Media Inquiries:
Organogenesis
Marcus Girolamo
 
817-688-4767

FAQ

What is the new presentation date for Organogenesis at the Oppenheimer Summit?

Organogenesis will present on September 21, 2020, at 2:30 p.m. Eastern Time.

Where can I watch the Organogenesis presentation webcast?

The webcast can be accessed via the 'Upcoming Events' section on Organogenesis's Investor Relations page.

How long will the Organogenesis webcast be available for replay?

The webcast will be available for replay for approximately 30 days after the conference.

Organogenesis Holdings Inc.

NASDAQ:ORGO

ORGO Rankings

ORGO Latest News

ORGO Stock Data

544.89M
74.82M
40.61%
48.28%
7.39%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
CANTON